APO Research
Talk to an analyst

APO RESEARCH · REPORT

Pediatric Obesity Management

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Pediatric Obesity Management Industry Growth and Trends Forecast to 2032

22 December 2025103 pages

Choose your research edition.

Industry ResearchPediatric Obesity Management Industry Research Report 2026123 pages · $2,950 USDIndustry Growth & TrendsGlobal Pediatric Obesity Management Industry Growth and Trends Forecast to 2032103 pages · $3,450 USDMarket StructureGlobal Pediatric Obesity Management Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Pediatric Obesity Management Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Pediatric Obesity Management Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global Pediatric Obesity Management market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Pediatric Obesity Management is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Pediatric Obesity Management is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Pediatric Obesity Management is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Pediatric Obesity Management include Takeda Pharmaceutical Company, Pfizer, GlaxoSmithKline, VIVUS, Herbalife, F.Hoffmann-La Roche, Ethicon, Inc., Currax Pharmaceuticals and AstraZeneca,, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Pediatric Obesity Management market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Pediatric Obesity Management market size, estimates, and forecasts are presented in terms of sales volume (k units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Pediatric Obesity Management market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Pediatric Obesity Management.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Pediatric Obesity Management market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Pediatric Obesity Management Market by Company

Takeda Pharmaceutical Company

Pfizer

GlaxoSmithKline

VIVUS

Herbalife

F.Hoffmann-La Roche

Ethicon, Inc.

Currax Pharmaceuticals

AstraZeneca,

ApolloEndosurgery

Pediatric Obesity Management Segment by Type

Phentermine

Liraglutide

Lorcaserin

Setmelanotide

Others

Pediatric Obesity Management Segment by Application

Online Pharmacies

Hospital Pharmacies

Retail Pharmacies

Pediatric Obesity Management Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pediatric Obesity Management market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Pediatric Obesity Management and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pediatric Obesity Management.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Pediatric Obesity Management manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Pediatric Obesity Management in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Phentermine Table 2. Major Company of Liraglutide Table 3. Major Company of Lorcaserin Table 4. Major Company of Setmelanotide Table 5. Major Company of Others Table 6. Global Pediatric Obesity Management Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Pediatric Obesity Management Sales by Type (2021-2026) & (k units) Table 8. Global Pediatric Obesity Management Sales Market Share in Volume by Type (2021-2026) Table 9. Global Pediatric Obesity Management Sales by Type (2021-2026) & (US$ Million) Table 10. Global Pediatric Obesity Management Sales Market Share in Value by Type (2021-2026) Table 11. Global Pediatric Obesity Management Price by Type (2021-2026) & (US$/unit) Table 12. Global Pediatric Obesity Management Sales by Type (2027-2032) & (k units) Table 13. Global Pediatric Obesity Management Sales Market Share in Volume by Type (2027-2032) Table 14. Global Pediatric Obesity Management Sales by Type (2027-2032) & (US$ Million) Table 15. Global Pediatric Obesity Management Sales Market Share in Value by Type (2027-2032) Table 16. Global Pediatric Obesity Management Price by Type (2027-2032) & (US$/unit) Table 17. North America Pediatric Obesity Management Sales by Type (2021-2026) & (k units) Table 18. North America Pediatric Obesity Management Sales by Type (2021-2026) & (US$ Million) Table 19. Europe Pediatric Obesity Management Sales by Type (2021-2026) & (k units) Table 20. Europe Pediatric Obesity Management Sales by Type (2021-2026) & (US$ Million) Table 21. Asia-Pacific Pediatric Obesity Management Sales by Type (2021-2026) & (k units) Table 22. Asia-Pacific Pediatric Obesity Management Sales by Type (2021-2026) & (US$ Million) Table 23. Latin America Pediatric Obesity Management Sales by Type (2021-2026) & (k units) Table 24. Latin America Pediatric Obesity Management Sales by Type (2021-2026) & (US$ Million) Table 25. Middle East and Africa Pediatric Obesity Management Sales by Type (2021-2026) & (k units) Table 26. Middle East and Africa Pediatric Obesity Management Sales by Type (2021-2026) & (US$ Million) Table 27. Pediatric Obesity Management Industry Trends Table 28. Pediatric Obesity Management Industry Drivers Table 29. Pediatric Obesity Management Industry Opportunities and Challenges Table 30. Pediatric Obesity Management Industry Restraints Table 31. Global Pediatric Obesity Management Sales Revenue by Company (US$ Million) & (2021-2026) Table 32. Global Pediatric Obesity Management Revenue Market Share by Company (2021-2026) Table 33. Global Pediatric Obesity Management Sales by Company (2021-2026) & (k units) Table 34. Global Pediatric Obesity Management Sales Share by Company (2021-2026) Table 35. Global Pediatric Obesity Management Market Price by Company (2021-2026) & (US$/unit) Table 36. Global Pediatric Obesity Management Industry Company Ranking, 2024 VS 2025 VS 2026 Table 37. Global Pediatric Obesity Management Major Company Production Sites and Headquarters Table 38. Global Pediatric Obesity Management Company, Product Type & Application Table 39. Global Pediatric Obesity Management Company Establishment Date Table 40. Global Company Market Concentration Ratio (CR5 and HHI) Table 41. Global Pediatric Obesity Management by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 42. Global Pediatric Obesity Management Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 43. Global Pediatric Obesity Management Sales by Region (2021-2026) & (k units) Table 44. Global Pediatric Obesity Management Sales Market Share in Volume by Region (2021-2026) Table 45. Global Pediatric Obesity Management Sales by Region (2021-2026) & (US$ Million) Table 46. Global Pediatric Obesity Management Sales Market Share in Value by Region (2021-2026) Table 47. Global Pediatric Obesity Management Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 48. Global Pediatric Obesity Management Sales by Region (2027-2032) & (k units) Table 49. Global Pediatric Obesity Management Sales Market Share in Volume by Region (2027-2032) Table 50. Global Pediatric Obesity Management Sales by Region (2027-2032) & (US$ Million) Table 51. Global Pediatric Obesity Management Sales Market Share in Value by Region (2027-2032) Table 52. Global Pediatric Obesity Management Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2027-2032) Table 53. Global Pediatric Obesity Management Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 54. Global Pediatric Obesity Management Sales by Application (2021-2026) & (k units) Table 55. Global Pediatric Obesity Management Sales Market Share in Volume by Application (2021-2026) Table 56. Global Pediatric Obesity Management Sales by Application (2021-2026) & (US$ Million) Table 57. Global Pediatric Obesity Management Sales Market Share in Value by Application (2021-2026) Table 58. Global Pediatric Obesity Management Price by Application (2021-2026) & (US$/unit) Table 59. Global Pediatric Obesity Management Sales by Application (2027-2032) & (k units) Table 60. Global Pediatric Obesity Management Sales Market Share in Volume by Application (2027-2032) Table 61. Global Pediatric Obesity Management Sales by Application (2027-2032) & (US$ Million) Table 62. Global Pediatric Obesity Management Sales Market Share in Value by Application (2027-2032) Table 63. Global Pediatric Obesity Management Price by Application (2027-2032) & (US$/unit) Table 64. North America Pediatric Obesity Management Sales by Application (2021-2026) & (k units) Table 65. North America Pediatric Obesity Management Sales by Application (2021-2026) & (US$ Million) Table 66. Europe Pediatric Obesity Management Sales by Application (2021-2026) & (k units) Table 67. Europe Pediatric Obesity Management Sales by Application (2021-2026) & (US$ Million) Table 68. Asia-Pacific Pediatric Obesity Management Sales by Application (2021-2026) & (k units) Table 69. Asia-Pacific Pediatric Obesity Management Sales by Application (2021-2026) & (US$ Million) Table 70. Latin America Pediatric Obesity Management Sales by Application (2021-2026) & (k units) Table 71. Latin America Pediatric Obesity Management Sales by Application (2021-2026) & (US$ Million) Table 72. Middle East and Africa Pediatric Obesity Management Sales by Application (2021-2026) & (k units) Table 73. Middle East and Africa Pediatric Obesity Management Sales by Application (2021-2026) & (US$ Million) Table 74. Takeda Pharmaceutical Company Company Information Table 75. Takeda Pharmaceutical Company Business Overview Table 76. Takeda Pharmaceutical Company Pediatric Obesity Management Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 77. Takeda Pharmaceutical Company Pediatric Obesity Management Product Portfolio Table 78. Takeda Pharmaceutical Company Recent Development Table 79. Pfizer Company Information Table 80. Pfizer Business Overview Table 81. Pfizer Pediatric Obesity Management Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 82. Pfizer Pediatric Obesity Management Product Portfolio Table 83. Pfizer Recent Development Table 84. GlaxoSmithKline Company Information Table 85. GlaxoSmithKline Business Overview Table 86. GlaxoSmithKline Pediatric Obesity Management Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 87. GlaxoSmithKline Pediatric Obesity Management Product Portfolio Table 88. GlaxoSmithKline Recent Development Table 89. VIVUS Company Information Table 90. VIVUS Business Overview Table 91. VIVUS Pediatric Obesity Management Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 92. VIVUS Pediatric Obesity Management Product Portfolio Table 93. VIVUS Recent Development Table 94. Herbalife Company Information Table 95. Herbalife Business Overview Table 96. Herbalife Pediatric Obesity Management Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 97. Herbalife Pediatric Obesity Management Product Portfolio Table 98. Herbalife Recent Development Table 99. F.Hoffmann-La Roche Company Information Table 100. F.Hoffmann-La Roche Business Overview Table 101. F.Hoffmann-La Roche Pediatric Obesity Management Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 102. F.Hoffmann-La Roche Pediatric Obesity Management Product Portfolio Table 103. F.Hoffmann-La Roche Recent Development Table 104. Ethicon, Inc. Company Information Table 105. Ethicon, Inc. Business Overview Table 106. Ethicon, Inc. Pediatric Obesity Management Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 107. Ethicon, Inc. Pediatric Obesity Management Product Portfolio Table 108. Ethicon, Inc. Recent Development Table 109. Currax Pharmaceuticals Company Information Table 110. Currax Pharmaceuticals Business Overview Table 111. Currax Pharmaceuticals Pediatric Obesity Management Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 112. Currax Pharmaceuticals Pediatric Obesity Management Product Portfolio Table 113. Currax Pharmaceuticals Recent Development Table 114. AstraZeneca, Company Information Table 115. AstraZeneca, Business Overview Table 116. AstraZeneca, Pediatric Obesity Management Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 117. AstraZeneca, Pediatric Obesity Management Product Portfolio Table 118. AstraZeneca, Recent Development Table 119. ApolloEndosurgery Company Information Table 120. ApolloEndosurgery Business Overview Table 121. ApolloEndosurgery Pediatric Obesity Management Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 122. ApolloEndosurgery Pediatric Obesity Management Product Portfolio Table 123. ApolloEndosurgery Recent Development Table 124. North America Pediatric Obesity Management Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 125. North America Pediatric Obesity Management Sales by Country (2021-2026) & (k units) Table 126. North America Pediatric Obesity Management Sales Market Share by Country (2021-2026) Table 127. North America Pediatric Obesity Management Sales Forecast by Country (2027-2032) & (k units) Table 128. North America Pediatric Obesity Management Sales Market Share Forecast by Country (2027-2032) Table 129. North America Pediatric Obesity Management Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 130. North America Pediatric Obesity Management Market Size by Country (2021-2026) & (US$ Million) Table 131. North America Pediatric Obesity Management Market Share by Country (2021-2026) Table 132. North America Pediatric Obesity Management Market Size Forecast by Country (2027-2032) & (US$ Million) Table 133. North America Pediatric Obesity Management Market Share Forecast by Country (2027-2032) Table 134. Europe Pediatric Obesity Management Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 135. Europe Pediatric Obesity Management Sales by Country (2021-2026) & (k units) Table 136. Europe Pediatric Obesity Management Sales Market Share by Country (2021-2026) Table 137. Europe Pediatric Obesity Management Sales Forecast by Country (2027-2032) & (k units) Table 138. Europe Pediatric Obesity Management Sales Market Share Forecast by Country (2027-2032) Table 139. Europe Pediatric Obesity Management Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 140. Europe Pediatric Obesity Management Market Size by Country (2021-2026) & (US$ Million) Table 141. Europe Pediatric Obesity Management Market Share by Country (2021-2026) Table 142. Europe Pediatric Obesity Management Market Size Forecast by Country (2027-2032) & (US$ Million) Table 143. Europe Pediatric Obesity Management Market Share Forecast by Country (2027-2032) Table 144. Asia-Pacific Pediatric Obesity Management Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 145. Asia-Pacific Pediatric Obesity Management Sales by Country (2021-2026) & (k units) Table 146. Asia-Pacific Pediatric Obesity Management Sales Market Share by Country (2021-2026) Table 147. Asia-Pacific Pediatric Obesity Management Sales Forecast by Country (2027-2032) & (k units) Table 148. Asia-Pacific Pediatric Obesity Management Sales Market Share Forecast by Country (2027-2032) Table 149. Asia-Pacific Pediatric Obesity Management Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 150. Asia-Pacific Pediatric Obesity Management Market Size by Country (2021-2026) & (US$ Million) Table 151. Asia-Pacific Pediatric Obesity Management Market Share by Country (2021-2026) Table 152. Asia-Pacific Pediatric Obesity Management Market Size Forecast by Country (2027-2032) & (US$ Million) Table 153. Asia-Pacific Pediatric Obesity Management Market Share Forecast by Country (2027-2032) Table 154. Latin America Pediatric Obesity Management Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 155. Latin America Pediatric Obesity Management Sales by Country (2021-2026) & (k units) Table 156. Latin America Pediatric Obesity Management Sales Market Share by Country (2021-2026) Table 157. Latin America Pediatric Obesity Management Sales Forecast by Country (2027-2032) & (k units) Table 158. Latin America Pediatric Obesity Management Sales Market Share Forecast by Country (2027-2032) Table 159. Latin America Pediatric Obesity Management Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 160. Latin America Pediatric Obesity Management Market Size by Country (2021-2026) & (US$ Million) Table 161. Latin America Pediatric Obesity Management Market Share by Country (2021-2026) Table 162. Latin America Pediatric Obesity Management Market Size Forecast by Country (2027-2032) & (US$ Million) Table 163. Latin America Pediatric Obesity Management Market Share Forecast by Country (2027-2032) Table 164. Middle East and Africa Pediatric Obesity Management Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 165. Middle East and Africa Pediatric Obesity Management Sales by Country (2021-2026) & (k units) Table 166. Middle East and Africa Pediatric Obesity Management Sales Market Share by Country (2021-2026) Table 167. Middle East and Africa Pediatric Obesity Management Sales Forecast by Country (2027-2032) & (k units) Table 168. Middle East and Africa Pediatric Obesity Management Sales Market Share Forecast by Country (2027-2032) Table 169. Middle East and Africa Pediatric Obesity Management Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 170. Middle East and Africa Pediatric Obesity Management Market Size by Country (2021-2026) & (US$ Million) Table 171. Middle East and Africa Pediatric Obesity Management Market Share by Country (2021-2026) Table 172. Middle East and Africa Pediatric Obesity Management Market Size Forecast by Country (2027-2032) & (US$ Million) Table 173. Middle East and Africa Pediatric Obesity Management Market Share Forecast by Country (2027-2032) Table 174. Key Raw Materials Table 175. Raw Materials Key Suppliers Table 176. Pediatric Obesity Management Distributors List Table 177. Pediatric Obesity Management Customers List Table 178. Research Programs/Design for This Report Table 179. Authors List of This Report Table 180. Secondary Sources Table 181. Primary Sources List of Figures Figure 1. Pediatric Obesity Management Image Figure 2. Global Pediatric Obesity Management Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Pediatric Obesity Management Market Size (2021-2032) & (US$ Million) Figure 4. Global Pediatric Obesity Management Sales (2021-2032) & (k units) Figure 5. Phentermine Image Figure 6. Global Phentermine Sales YoY Growth (2021-2032) & (k units) Figure 7. Liraglutide Image Figure 8. Global Liraglutide Sales YoY Growth (2021-2032) & (k units) Figure 9. Lorcaserin Image Figure 10. Global Lorcaserin Sales YoY Growth (2021-2032) & (k units) Figure 11. Setmelanotide Image Figure 12. Global Setmelanotide Sales YoY Growth (2021-2032) & (k units) Figure 13. Others Image Figure 14. Global Others Sales YoY Growth (2021-2032) & (k units) Figure 15. Global Pediatric Obesity Management Market Size Overview by Type (2021-2032) & (US$ Million) Figure 16. Global Pediatric Obesity Management Market Share by Type 2025 VS 2032 Figure 17. North America Pediatric Obesity Management Sales Market Share in Volume by Type in 2025 Figure 18. North America Pediatric Obesity Management Sales Market Share in Value by Type in 2025 Figure 19. Europe Pediatric Obesity Management Sales Market Share in Volume by Type in 2025 Figure 20. Europe Pediatric Obesity Management Sales Market Share in Value by Type in 2025 Figure 21. Asia-Pacific Pediatric Obesity Management Sales Market Share in Volume by Type in 2025 Figure 22. Asia-Pacific Pediatric Obesity Management Sales Market Share in Value by Type in 2025 Figure 23. Latin America Pediatric Obesity Management Sales Market Share in Volume by Type in 2025 Figure 24. Latin America Pediatric Obesity Management Sales Market Share in Value by Type in 2025 Figure 25. Middle East and Africa Pediatric Obesity Management Sales Market Share in Volume by Type in 2025 Figure 26. Middle East and Africa Pediatric Obesity Management Sales Market Share in Value by Type in 2025 Figure 27. Global Top 5 and 10 Pediatric Obesity Management Players Market Share by Revenue in 2025 Figure 28. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 29. Online Pharmacies Image Figure 30. Global Online Pharmacies Sales YoY Growth (2021-2032) & (k units) Figure 31. Hospital Pharmacies Image Figure 32. Global Hospital Pharmacies Sales YoY Growth (2021-2032) & (k units) Figure 33. Retail Pharmacies Image Figure 34. Global Retail Pharmacies Sales YoY Growth (2021-2032) & (k units) Figure 35. Global Pediatric Obesity Management Market Size Overview by Application (2021-2032) & (US$ Million) Figure 36. Global Pediatric Obesity Management Market Share by Application 2025 VS 2032 Figure 37. North America Pediatric Obesity Management Sales Market Share in Volume by Application in 2025 Figure 38. North America Pediatric Obesity Management Sales Market Share in Value by Application in 2025 Figure 39. Europe Pediatric Obesity Management Sales Market Share in Volume by Application in 2025 Figure 40. Europe Pediatric Obesity Management Sales Market Share in Value by Application in 2025 Figure 41. Asia-Pacific Pediatric Obesity Management Sales Market Share in Volume by Application in 2025 Figure 42. Asia-Pacific Pediatric Obesity Management Sales Market Share in Value by Application in 2025 Figure 43. Latin America Pediatric Obesity Management Sales Market Share in Volume by Application in 2025 Figure 44. Latin America Pediatric Obesity Management Sales Market Share in Value by Application in 2025 Figure 45. Middle East and Africa Pediatric Obesity Management Sales Market Share in Volume by Application in 2025 Figure 46. Middle East and Africa Pediatric Obesity Management Sales Market Share in Value by Application in 2025 Figure 47. North America Pediatric Obesity Management Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 48. North America Pediatric Obesity Management Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. North America Pediatric Obesity Management Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. North America Pediatric Obesity Management Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe Pediatric Obesity Management Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 52. Europe Pediatric Obesity Management Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Europe Pediatric Obesity Management Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Europe Pediatric Obesity Management Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Asia-Pacific Pediatric Obesity Management Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 56. Asia-Pacific Pediatric Obesity Management Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Asia-Pacific Pediatric Obesity Management Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Asia-Pacific Pediatric Obesity Management Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America Pediatric Obesity Management Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 60. Latin America Pediatric Obesity Management Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Latin America Pediatric Obesity Management Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Latin America Pediatric Obesity Management Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Middle East and Africa Pediatric Obesity Management Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 64. Middle East and Africa Pediatric Obesity Management Sales Share by Country: 2021 VS 2025 VS 2032 Figure 65. Middle East and Africa Pediatric Obesity Management Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 66. Middle East and Africa Pediatric Obesity Management Market Share by Country: 2021 VS 2025 VS 2032 Figure 67. Pediatric Obesity Management Value Chain Figure 68. Key Raw Materials Price Figure 69. Manufacturing Cost Structure Figure 70. Pediatric Obesity Management Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • Phentermine
  • Liraglutide
  • Lorcaserin
  • Setmelanotide
  • Others
Applications
  • Online Pharmacies
  • Hospital Pharmacies
  • Retail Pharmacies
Companies covered
  • Takeda Pharmaceutical Company
  • Pfizer
  • GlaxoSmithKline
  • VIVUS
  • Herbalife
  • F.Hoffmann-La Roche
  • Ethicon, Inc.
  • Currax Pharmaceuticals
  • AstraZeneca,
  • ApolloEndosurgery

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Pediatric Obesity Management Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Pediatric Obesity Management Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Pediatric Obesity Management Market by Type
  6. 1.3.1 Phentermine
  7. 1.3.2 Liraglutide
  8. 1.3.3 Lorcaserin
  9. 1.3.4 Setmelanotide
  10. 1.3.5 Others
  11. 1.4 Global Pediatric Obesity Management Market Size by Type
  12. 1.4.1 Global Pediatric Obesity Management Market Size Overview by Type (2021-2032)
  13. 1.4.2 Global Pediatric Obesity Management Historic Market Size Review by Type (2021-2026)
  14. 1.4.3 Global Pediatric Obesity Management Forecasted Market Size by Type (2027-2032)
  15. 1.5 Key Regions Market Size by Type
  16. 1.5.1 North America Pediatric Obesity Management Sales Breakdown by Type (2021-2026)
  17. 1.5.2 Europe Pediatric Obesity Management Sales Breakdown by Type (2021-2026)
  18. 1.5.3 Asia-Pacific Pediatric Obesity Management Sales Breakdown by Type (2021-2026)
  19. 1.5.4 South America Pediatric Obesity Management Sales Breakdown by Type (2021-2026)
  20. 1.5.5 Middle East and Africa Pediatric Obesity Management Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Pediatric Obesity Management Industry Trends
  2. 2.2 Pediatric Obesity Management Industry Drivers
  3. 2.3 Pediatric Obesity Management Industry Opportunities and Challenges
  4. 2.4 Pediatric Obesity Management Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Pediatric Obesity Management Revenue (2021-2026)
  2. 3.2 Global Top Players by Pediatric Obesity Management Sales (2021-2026)
  3. 3.3 Global Top Players by Pediatric Obesity Management Price (2021-2026)
  4. 3.4 Global Pediatric Obesity Management Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Pediatric Obesity Management Major Company Production Sites & Headquarters
  6. 3.6 Global Pediatric Obesity Management Company, Product Type & Application
  7. 3.7 Global Pediatric Obesity Management Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Pediatric Obesity Management Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Pediatric Obesity Management Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Pediatric Obesity Management Tier 1, Tier 2, and Tier 3
4 Pediatric Obesity Management Regional Status and Outlook
  1. 4.1 Global Pediatric Obesity Management Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Pediatric Obesity Management Historic Market Size by Region
  3. 4.2.1 Global Pediatric Obesity Management Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Pediatric Obesity Management Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Pediatric Obesity Management Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Pediatric Obesity Management Forecasted Market Size by Region
  7. 4.3.1 Global Pediatric Obesity Management Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Pediatric Obesity Management Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Pediatric Obesity Management Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Pediatric Obesity Management by Application
  1. 5.1 Pediatric Obesity Management Market by Application
  2. 5.1.1 Online Pharmacies
  3. 5.1.2 Hospital Pharmacies
  4. 5.1.3 Retail Pharmacies
  5. 5.2 Global Pediatric Obesity Management Market Size by Application
  6. 5.2.1 Global Pediatric Obesity Management Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Pediatric Obesity Management Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Pediatric Obesity Management Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Pediatric Obesity Management Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Pediatric Obesity Management Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Pediatric Obesity Management Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Pediatric Obesity Management Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Pediatric Obesity Management Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Takeda Pharmaceutical Company
  2. 6.1.1 Takeda Pharmaceutical Company Company Information
  3. 6.1.2 Takeda Pharmaceutical Company Business Overview
  4. 6.1.3 Takeda Pharmaceutical Company Pediatric Obesity Management Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Takeda Pharmaceutical Company Pediatric Obesity Management Product Portfolio
  6. 6.1.5 Takeda Pharmaceutical Company Recent Developments
  7. 6.2 Pfizer
  8. 6.2.1 Pfizer Company Information
  9. 6.2.2 Pfizer Business Overview
  10. 6.2.3 Pfizer Pediatric Obesity Management Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Pfizer Pediatric Obesity Management Product Portfolio
  12. 6.2.5 Pfizer Recent Developments
  13. 6.3 GlaxoSmithKline
  14. 6.3.1 GlaxoSmithKline Company Information
  15. 6.3.2 GlaxoSmithKline Business Overview
  16. 6.3.3 GlaxoSmithKline Pediatric Obesity Management Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 GlaxoSmithKline Pediatric Obesity Management Product Portfolio
  18. 6.3.5 GlaxoSmithKline Recent Developments
  19. 6.4 VIVUS
  20. 6.4.1 VIVUS Company Information
  21. 6.4.2 VIVUS Business Overview
  22. 6.4.3 VIVUS Pediatric Obesity Management Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 VIVUS Pediatric Obesity Management Product Portfolio
  24. 6.4.5 VIVUS Recent Developments
  25. 6.5 Herbalife
  26. 6.5.1 Herbalife Company Information
  27. 6.5.2 Herbalife Business Overview
  28. 6.5.3 Herbalife Pediatric Obesity Management Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Herbalife Pediatric Obesity Management Product Portfolio
  30. 6.5.5 Herbalife Recent Developments
  31. 6.6 F.Hoffmann-La Roche
  32. 6.6.1 F.Hoffmann-La Roche Company Information
  33. 6.6.2 F.Hoffmann-La Roche Business Overview
  34. 6.6.3 F.Hoffmann-La Roche Pediatric Obesity Management Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 F.Hoffmann-La Roche Pediatric Obesity Management Product Portfolio
  36. 6.6.5 F.Hoffmann-La Roche Recent Developments
  37. 6.7 Ethicon, Inc.
  38. 6.7.1 Ethicon, Inc. Company Information
  39. 6.7.2 Ethicon, Inc. Business Overview
  40. 6.7.3 Ethicon, Inc. Pediatric Obesity Management Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Ethicon, Inc. Pediatric Obesity Management Product Portfolio
  42. 6.7.5 Ethicon, Inc. Recent Developments
  43. 6.8 Currax Pharmaceuticals
  44. 6.8.1 Currax Pharmaceuticals Company Information
  45. 6.8.2 Currax Pharmaceuticals Business Overview
  46. 6.8.3 Currax Pharmaceuticals Pediatric Obesity Management Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Currax Pharmaceuticals Pediatric Obesity Management Product Portfolio
  48. 6.8.5 Currax Pharmaceuticals Recent Developments
  49. 6.9 AstraZeneca,
  50. 6.9.1 AstraZeneca, Company Information
  51. 6.9.2 AstraZeneca, Business Overview
  52. 6.9.3 AstraZeneca, Pediatric Obesity Management Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 AstraZeneca, Pediatric Obesity Management Product Portfolio
  54. 6.9.5 AstraZeneca, Recent Developments
  55. 6.10 ApolloEndosurgery
  56. 6.10.1 ApolloEndosurgery Company Information
  57. 6.10.2 ApolloEndosurgery Business Overview
  58. 6.10.3 ApolloEndosurgery Pediatric Obesity Management Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 ApolloEndosurgery Pediatric Obesity Management Product Portfolio
  60. 6.10.5 ApolloEndosurgery Recent Developments
7 North America by Country
  1. 7.1 North America Pediatric Obesity Management Sales by Country
  2. 7.1.1 North America Pediatric Obesity Management Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Pediatric Obesity Management Sales by Country (2021-2026)
  4. 7.1.3 North America Pediatric Obesity Management Sales Forecast by Country (2027-2032)
  5. 7.2 North America Pediatric Obesity Management Market Size by Country
  6. 7.2.1 North America Pediatric Obesity Management Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Pediatric Obesity Management Market Size by Country (2021-2026)
  8. 7.2.3 North America Pediatric Obesity Management Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Pediatric Obesity Management Sales by Country
  2. 8.1.1 Europe Pediatric Obesity Management Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Pediatric Obesity Management Sales by Country (2021-2026)
  4. 8.1.3 Europe Pediatric Obesity Management Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Pediatric Obesity Management Market Size by Country
  6. 8.2.1 Europe Pediatric Obesity Management Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Pediatric Obesity Management Market Size by Country (2021-2026)
  8. 8.2.3 Europe Pediatric Obesity Management Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Pediatric Obesity Management Sales by Country
  2. 9.1.1 Asia-Pacific Pediatric Obesity Management Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Pediatric Obesity Management Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Pediatric Obesity Management Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Pediatric Obesity Management Market Size by Country
  6. 9.2.1 Asia-Pacific Pediatric Obesity Management Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Pediatric Obesity Management Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Pediatric Obesity Management Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Pediatric Obesity Management Sales by Country
  2. 10.1.1 South America Pediatric Obesity Management Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Pediatric Obesity Management Sales by Country (2021-2026)
  4. 10.1.3 South America Pediatric Obesity Management Sales Forecast by Country (2027-2032)
  5. 10.2 South America Pediatric Obesity Management Market Size by Country
  6. 10.2.1 South America Pediatric Obesity Management Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Pediatric Obesity Management Market Size by Country (2021-2026)
  8. 10.2.3 South America Pediatric Obesity Management Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Pediatric Obesity Management Sales by Country
  2. 11.1.1 Middle East and Africa Pediatric Obesity Management Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Pediatric Obesity Management Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Pediatric Obesity Management Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Pediatric Obesity Management Market Size by Country
  6. 11.2.1 Middle East and Africa Pediatric Obesity Management Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Pediatric Obesity Management Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Pediatric Obesity Management Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Pediatric Obesity Management Value Chain Analysis
  2. 12.1.1 Pediatric Obesity Management Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Pediatric Obesity Management Production Mode & Process
  7. 12.2 Pediatric Obesity Management Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Pediatric Obesity Management Distributors
  10. 12.2.3 Pediatric Obesity Management Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst